SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABT - Abbott Labs
ABT 124.50-1.7%3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Nicholas who wrote (317)10/3/2000 9:17:27 AM
From: Skywatcher   of 328
 
Biocompatibles stent clears U.S. hurdle
LONDON, Oct 3 (Reuters) - Medical devices company Biocompatibles International Plc said on Tuesday that the U.S. Food and Drug Administration had given pre-market approval (PMA) for its key stent product used to open arteries.
The company received an approvable letter on its BiodivYsio stents from the FDA earlier this month.
Crispin Simon, Chief Executive of Biocompatibles, said ``the PMA approval for our BiodivYsio stent is a major milestone for the company.''
The stents, tiny pieces of expandable steel tubing, are due to reach the U.S. market in 2001. Abbott Laboratories (NYSE:ABT - news) will distribute the product.
More $$$...that's good
chris
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext